SARS-CoV-2 Nucleic Acidum Detection Kit (Multiplex PCR Fluorescent Probe Methodo)
Intentum usum
Hoc ornamentum reali-time RT PCR technologiae (rRT-PCR) ad detectionem qualitativae acidi nuclei SARS-CoV-2 in exemplis nasopharyngealibus vel oropharyngeis swab humanorum exemplis utitur.
Principium temptationis
Hic primarius et specillus primus designatur ad detectionem sequentium conservatorum SARS-CoV-2 (ORF1ab gene et N gene).Ornamentum continet Imperium Internum, quod specimine qualitatis aestimandae adhibetur.
Real-time PCR technology utitur polymerase catenae reactionem (PCR) ad amplificationem specificam scopum
sequentia et clypeum specificum rimatur ad RNA detectionem ampliandam.Intitulatum speculatoria cum
notario fluorescent et restinguere tinguit.
Velox Details
◮Formularium:48 Rxns/ornamentum, 96 Rxns/ornamentum
◮ Specification:96.72%
Sensibilitas:97.92%
Applicable specimen types
Swab Nasopharyngeal Swab oropharyngeal
◮Lorem instrumentum
ABI7500, Bio-Rad CFX96, Roche LightCycler 480, SLAN-96S
Components
Nec. | Component | Moles | Principalis components | |||
48 Rxns | 96 Rxns | |||||
1 | Acidum nucleicum emissio agentis | 1.4mL/tube | 2 tube | 5.3 mL/utrem | I utrem | Surfactant |
2 | RNA protector | 27 μL/tube | 1 tube | 53 μL/tube | 1 tube | RNase inhibitor |
3 | Sars-CoV-2 solutionem reactionem | 800 μL/tube | 1 tube | 1600 μL/tube | 1 tube | De primario, specillo, quiddam reactionis, dNTP |
4 | SARS-CoV-2 mixtura enzyme | 80 μL/tube | 1 tube | 160 μL/tube | 1 tube | Initium calidum Taq enzyme, M-MLV enzyme |
5 | Sars-CoV-2 imperium positivum | 100 μL/tube | 1 tube | 100 μL/tube | 1 tube | Recombinante plasmida continens scopum fragmentum, RNA |
6 | Sars-CoV-2 imperium negativum | 1200 μL/tube | 1 tube | 1200 μL/tube | 1 tube | quiddam TE |
Features & commoda
◮Direct Pcr
Nucleici acidi exactionis ornamentum et systema nullum opus, perfecto 96 specimine in 1 hora vel sic.
◮Humilis armorum postulationem et usum flflexible altus
Tantum opus est systema real-time pcr.
◮LoD et altum sensitivum
Deprehensio sensibilitas infimum pervenire potest sicut exemplaria 500/ml.
Quomodo uti
Modus I: Dirige Pcr modum
Modus 2: Viral RNA Isolation + PCR
Modus I: Dirige Pcr modum utendiSample Release agentis
Frigidum Chain Transportation and Repono
Signatum a lumine et conditum ad -20±5℃;
Fasciae vita
I anno
Informationes iussis
Velox Operatio video
Epistulam tuam hic scribe et mitte nobis